SEID PAUL purchased $948 of INLX

SEID PAUL purchased 184 shares of INTELLINETICS, INC. (INLX) at $5.15 across 2 trades over 2026-09-28 to 2026-09-30.

Original reporting
SEC EDGAR · SEID PAUL
Published Sep 30, 2026, 9:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$INLX
Neutral
medium confidence
Mentioned
$INLX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INLXNeutralLow
01

Why it matters

The transaction is modest in size and unlikely to move the stock materially.

02

Market read

Minor relevance; provides a data point for insiders monitoring but limited trading impact.

03

What to watch

Potential upcoming corporate actions or financing events not disclosed.

Relevance 4/10Novelty 4/10Timing: same-day filing

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$INLXNeutralMedium confidence
Context

Director Seid Paul bought 184 shares of Intellinetics for $947.60, increasing his holdings to 192,610 shares.

Expected impact

minor upward pressure as market absorbs insider buying

Evidence & confidence

Purchase amount is under $1M and represents a tiny fraction of float, limiting material impact.

Market effects

None significant; insider activity does not affect sector outlook.

No regional effect.

Limited to investors tracking Intellinetics.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a bullish signal.

Key entities

  • Intellinetics, Inc.

    Biotech firm listed on US exchanges under ticker INLX.

  • Seid Paul

    Director of Intellinetics who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INLXMed

Intellinetics Reports Second Quarter and Six-Month 2026 Results

INTELLINETICS, INC. (INLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Intellinetics Reports Second Quarter and Six-Month 2026 Results COLUMBUS, OH – August 12, 2026 – Intellinetics, Inc. ( NYSE American: INLX ), a digital transformation solutions provider, announced financial results for the three and six months ended June 30, 2026. 20

$CTEVLow

ARES MANAGEMENT LLC purchased $2.9M of CTEV (indirect holdings)

ARES MANAGEMENT LLC purchased 115,579 indirectly-held shares of Claritev Corp (CTEV) at an average of $25.40 ($24.42–$26.14, $2.94M total) across 2 trades over 2026-11-09 to 2026-11-10. Filed jointly with ASOF Investment Management LLC (10% owner), Ares Management Holdings L.P. (10% owner), Ares Holdco LLC (10% owner), Ares Management Corp (10% owner), Ares Voting LLC (10% owner), Ares Management GP LLC (10% owner) and Ares Partners Holdco LLC (10% owner).